Infliximab in Ulcerative Colitis is Associated with an Increased Risk of Postoperative Complications After Restorative Proctocolectomy
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
PURPOSE: Little data exist regarding infliximab use in surgical decision making and postoperative complications in ulcerative colitis. Our goals were to determine the rate of postoperative complications in infliximab-treated ulcerative colitis patients undergoing restorative proctocolectomy and to determine whether three-stage procedures are more often necessary. METHODS: We studied a group of infliximab-treated patients and matched control subjects who underwent two-stage restorative proctocolectomy between 2000 and 2006. Postoperative complications were compared. In addition, the rate of three-stage procedures was compared between all infliximab- and noninfliximab-treated patients. RESULTS: A total of 523 restorative proctocolectomies were performed. In the infliximab group, there were 46 two-stage and 39 three-stage procedures. Covariate-adjusted odds of early complication for the infliximab group was 3.54 times that of controls (P = 0.004; 95 percent confidence interval (CI), 1.51-8.31). The odds of sepsis were 13.8 times greater (P = 0.011; 95 percent CI, 1.82-105) and the odds of late complication were 2.19 times greater (P = 0.08; 95 percent CI, 0.91-5.28) for infliximab. The odds of requirement for three-stage procedures was 2.07 times greater in the infliximab group (P = 0.011; 95 percent CI, 1.18-3.63). CONCLUSIONS: Infliximab increases the risk of postoperative complications after restorative proctocolectomy and has altered the surgical approach to ulcerative colitis. Potential benefits of infliximab should be balanced against these risks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Proctocolectomy without ileostomy for ulcerative colitis.
Parks, A. G., & Nicholls, R. J. (1978) · BMJ · doi:10.1136/bmj.2.6130.85 · Cited by 1,355
IIeal Pouch-Anal Anastomoses Complications and Function in 1005 Patients
Fazio, V. W., Ziv, Y., Church, J. M., Oakley, J. R., Lavery, I. C., Milsom, J. W., & Schroeder, T. K. (1995) · Annals of Surgery · doi:10.1097/00000658-199508000-00003 · Cited by 1,204
Järnerot, G., Hertervig, E., Friis-Liby, I., Blomquist, L., Karlén, P., Grännö, C., Vilien, M., Ström, M., Danielsson, Å., Verbaan, H., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.003 · Cited by 1,089
Laboratory markers in IBD: useful, magic, or unnecessary toys?
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2006) · Gut · doi:10.1136/gut.2005.069476 · Cited by 952
Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry
Lichtenstein, G. R., Feagan, B. G., Cohen, R. D., Salzberg, B. A., Diamond, R. H., Chen, D. M., Pritchard, M. L., & Sandborn, W. J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.002 · Cited by 905
Colombel, J.-F., Loftus, E. V., Tremaine, W. J., Egan, L. J., Harmsen, W. S., Schleck, C. D., Zinsmeister, A. R., & Sandborn, W. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.047 · Cited by 899
Long-Term Functional Outcome and Quality of Life After Stapled Restorative Proctocolectomy
Fazio, V. W., O’Riordain, M. G., Lavery, I. C., Church, J. M., Lau, P., Strong, S. A., & Hull, T. (1999) · Annals of Surgery · doi:10.1097/00000658-199910000-00013 · Cited by 453
Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study
Sands, B. E., Tremaine, W. J., Sandborn, W. J., Rutgeerts, P. J., Hanauer, S. B., Mayer, L., Targan, S. R., & Podolsky, D. K. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200105000-00001 · Cited by 422
Colombel, J. F., Loftus, E. V., Tremaine, W. J., Pemberton, J. H., Wolff, B. G., Young-Fadok, T., Harmsen, W. S., Schleck, C. D., & Sandborn, W. J. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04148.x · Cited by 381
Mean platelet volume: a useful marker of inflammatory bowel disease activity
Kapsoritakis, A. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02414-x · Cited by 358
Probert, C. S. J., Hearing, S. D., Schreiber, S., Kühbacher, T., Ghosh, S., Arnott, I. D. R., & Forbes, A. (2003) · Gut · doi:10.1136/gut.52.7.998 · Cited by 355
Selvasekar, C. R., Cima, R. R., Larson, D. W., Dozois, E. J., Harrington, J. R., Harmsen, W. S., Loftus, E. V., Sandborn, W. J., Wolff, B. G., & Pemberton, J. H. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2006.12.044 · Cited by 328
Platelets in Inflammatory Bowel Disease: Clinical, Pathogenic, and Therapeutic Implications
Danese, S., Motte, C. D. L., & Fiocchi, C. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04129.x · Cited by 253
Marchal, L., D'Haens, G., Van Assche, G., Vermeire, S., Noman, M., Ferrante, M., Hiele, M., Bueno De Mesquita, M., D'Hoore, A., Penninckx, F., et al. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01904.x · Cited by 222
Laboratory Values for Children With Newly Diagnosed Inflammatory Bowel Disease
Mack, D. R., Langton, C., Markowitz, J., LeLeiko, N., Griffiths, A., Bousvaros, A., Evans, J., Kugathasan, S., Otley, A., Pfefferkorn, M., et al. (2007) · Pediatrics · doi:10.1542/peds.2006-1865 · Cited by 178
Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis
Su, C. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04384-8 · Cited by 175
Infliximab for refractory ulcerative colitis
Chey, W. Y., Hussain, A., Ryan, C., Potter, G. D., & Shah, A. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04039.x · Cited by 138
Schluender, S. J., Ippoliti, A., Dubinsky, M. C., Vasiliauskas, E. A., Papadakis, K. A., Mei, L., Targan, S. R., & Fleshner, P. R. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-9008-3 · Cited by 135
Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study
Ochsenkühn, T., Sackmann, M. F., & Göke, B. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00014 · Cited by 124
Kohn, A., Prantera, C., Pera, A., Cosintino, R., Sostegni, R., & Daperno, M. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80204-3 · Cited by 85
Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease
Sandborn, W. J., & Loftus, E. V. (2004) · Gut · doi:10.1136/gut.2003.020552 · Cited by 71
Cited by
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Kobayashi, T., Siegmund, B., Le Berre, C., Wei, S. C., Ferrante, M., Shen, B., Bernstein, C. N., Danese, S., Peyrin-Biroulet, L., & Hibi, T. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0205-x · Cited by 1,649
Self-citationDignass, A., Lindsay, J. O., Sturm, A., Windsor, A., Colombel, J.-F., Allez, M., D'Haens, G., D'Hoore, A., Mantzaris, G., Novacek, G., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.002 · Cited by 1,548
Guidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A., Ahmad, T., Arnott, I., Driscoll, R., Mitton, S., Orchard, T., Rutter, M., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,419
A comprehensive review and update on ulcerative colitis,
Gajendran, M., Loganathan, P., Jimenez, G., Catinella, A. P., Ng, N., Umapathy, C., Ziade, N., & Hashash, J. G. (2019) · Disease-a-Month · doi:10.1016/j.disamonth.2019.02.004 · Cited by 638
Metadata
- Authors
- Mor, I. J., Vogel, J. D., da Luz Moreira, A., Shen, B., Hammel, J., & Remzi, F. H.
- Venue
- Diseases of the Colon & Rectum
- Published
- 2008-08
- Volume
- 51
- Issue
- 8
- Pages
- 1202-1210
- ISSN
- 0012-3706 (ISSN-L)
- OpenAlex
- W1996835391
- Cited by
- 297
- References
- 22
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.